CHARLOTTE HARDESTY: Open Payments
NPI 1104504398 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 21 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $243 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $72 |
| UCB, Inc. | 3 | $72 |
| SpringWorks Therapeutics, Inc. | 2 | $50 |
| Mallinckrodt Hospital Products Inc. | 1 | $36 |
| ARGENX US, INC. | 2 | $33 |
| Medtronic, Inc. | 1 | $28 |
| Smith+Nephew, Inc. | 1 | $22 |
| Neurelis, Inc. | 1 | $21 |
| EMD Serono, Inc. | 1 | $19 |
| Grifols USA, LLC | 1 | $19 |
Products named: HYQVIA, Rystiggo, GOMEKLI, ACTHAR, DUET, PICO 7, VALTOCO, Gamunex-C.
Industry payments across KY — which companies pay providers there.
